{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:19:07Z","timestamp":1761805147943,"version":"build-2065373602"},"reference-count":70,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    This study aimed to report the effects of policosanol (20\u00a0mg\/day) on blood pressure values in Cuban patients with grade I hypertension. A double\u2010blind multicenter trial randomized 400 eligible patients divided into two strata of patients with either prehypertension or grade I hypertension (200 patients each) treated with either placebo or policosanol 20\u00a0mg\/day (100 patients\/group\/stratum) for 12 weeks. Having published the results of pre\u2010hypertensive patients, here we report the grade I hypertension stratum (SBP 140\u2013159\u00a0mmHg, DBP 90\u201399\u00a0mmHg) results. The primary outcome targeted whether policosanol could achieve significant systolic blood pressure (SBP) reductions \u226510\u00a0mmHg versus baseline and significantly different from placebo. Changes in diastolic blood pressure (DBP) and lipid profile variables were secondary outcomes. Safety indicators and adverse events were assessed. Statistical analyses were conducted by Intention to Treat. Both groups were similar at randomization. At study completion, policosanol significantly lowered (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001) SBP, the primary outcome, by more than 10\u00a0mmHg related to baseline and placebo, while also significantly decreasing (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001) DBP values versus baseline and placebo. Also, more (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001) policosanol patients reached SBP reductions \u226510\u00a0mmHg and DBP reductions \u22655\u00a0mmHg versus baseline (74% and 91%, respectively) than placebo patients (12% and 15%, respectively). Policosanol significantly lowered low\u2010density lipoprotein\u2010cholesterol (LDL\u2010C) and total cholesterol, while increasing high\u2010density lipoprotein\u2010cholesterol (HDL\u2010C). It is concluded that oral administration of policosanol 20\u00a0mg\/day for twelve weeks significantly lowered SBP and DBP in Cuban patients with grade I hypertension, and improved lipid profile variables, being safe and well tolerated.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Trial registration<\/jats:bold>\n                    : Cuban Public Registry of Clinical Trials identifier: RPCEC00000377; IRB approval number: IRB\u2010120721.\n                  <\/jats:p>","DOI":"10.1111\/jch.70126","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:30:33Z","timestamp":1759339833000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Policosanol (sugarcane wax alcohols) 20\u00a0mg\/day in Cuban Patients With Grade I Hypertension: A Randomized, Double\u2010Blind, Multicenter Study"],"prefix":"10.1111","volume":"27","author":[{"given":"Moura","family":"Revueltas Aguero","sequence":"first","affiliation":[{"name":"National Institute of Hygiene Epidemiology and Microbiology  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarilys","family":"Jimenez Chiquet","sequence":"additional","affiliation":[{"name":"National Institute of Hygiene Epidemiology and Microbiology  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamile","family":"Valdes","sequence":"additional","affiliation":[{"name":"Calixto Garc\u00eda Hospital  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-4129","authenticated-orcid":false,"given":"Julio C\u00e9sar","family":"Fern\u00e1ndez Travieso","sequence":"additional","affiliation":[{"name":"National Centre for Scientific Research  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yenney","family":"Reyes Nu\u00f1ez","sequence":"additional","affiliation":[{"name":"National Centre for Scientific Research  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanay","family":"Fern\u00e1ndez Dominguez","sequence":"additional","affiliation":[{"name":"National Centre for Scientific Research  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Gonz\u00e1lez Pla","sequence":"additional","affiliation":[{"name":"National Centre for Scientific Research  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarahi","family":"Mendoza Casta\u00f1o","sequence":"additional","affiliation":[{"name":"National Centre for Scientific Research  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohani","family":"P\u00e9rez Guerra","sequence":"additional","affiliation":[{"name":"National Centre for Scientific Research  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Delfin","family":"P\u00e9rez Caballero","sequence":"additional","affiliation":[{"name":"Hermanos Ameijeiras Hospital  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deisy","family":"Navarro","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Cruz Gomez","sequence":"additional","affiliation":[{"name":"Medical Surgical Research Centre  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilis","family":"Mesa Angarica","sequence":"additional","affiliation":[{"name":"Medical Surgical Research Centre  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys","family":"Jim\u00e9nez Rivero","sequence":"additional","affiliation":[{"name":"Cuba's National Clinical Trials Coordinating Centre  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"S\u00e1nchez Texido","sequence":"additional","affiliation":[{"name":"Cuba's National Clinical Trials Coordinating Centre  Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"and the Family's Doctors of the Polyclinical Centres of Plaza Municipality","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,10]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000757"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30752-2"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803180"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.6015"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003480"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001168"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178"},{"key":"e_1_2_11_11_1","unstructured":"M. D.P\u00e9rez Y.Vald\u00e9s L.P\u00e9rez C.L\u00f3pez A.Jim\u00e9nez andP.Ord\u00fa\u00f1ez \u201cHipertensi\u00f3n Arterial en el Adulto. Gu\u00eda de Actuaci\u00f3n para la Atenci\u00f3n Primaria de Salud \u201dPrograma Nacional de Prevenci\u00f3n Diagn\u00f3stico Evaluaci\u00f2n y Control de la Hipertensi\u00f3n Arterial de Cuba\/HEARTS en las Am\u00e9ricas. Representaci\u00f3n en Cuba OPS\/OMS.2021."},{"key":"e_1_2_11_12_1","article-title":"Effect of Intensive Blood Pressure Control and Comorbidity Status on the Prognosis of Patients With Hypertension: Insights From SPRINT","volume":"12","author":"Peng X.","year":"2023","journal-title":"Journal of the American Heart Association"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(05)80631-9"},{"key":"e_1_2_11_14_1","first-page":"159","article-title":"A Two\u2010Year Study on the Efficacy and Tolerability of Policosanol in Patients With Type II Hyperlipoproteinaemia","volume":"15","author":"Canetti M.","year":"1995","journal-title":"International Journal of Clinical Pharmacology Research"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.3.393"},{"issue":"1","key":"e_1_2_11_16_1","first-page":"31","article-title":"Efficacy and Tolerability of Policosanol in Hypercholesterolemic Postmenopausal Women","volume":"21","author":"Mirkin A.","year":"2001","journal-title":"International Journal of Clinical Pharmacology Research"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70139-6"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/00126839-200203030-00004"},{"issue":"1","key":"e_1_2_11_19_1","first-page":"485","article-title":"Effects of Policosanol on Lipid Profile and Cardiac Events in Older Hypercholesterolemic Patients With Coronary Disease","volume":"21","author":"Mas R.","year":"2001","journal-title":"Clinical Drug Investigation"},{"issue":"3","key":"e_1_2_11_20_1","first-page":"137","article-title":"Functional Improvement in Coronary Artery Disease After 20 Months of Lipid\u2010Lowering Therapy With Policosanol","volume":"13","author":"Batista J. F.","year":"1996","journal-title":"Advances in Therapy"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(97)80099-9"},{"key":"e_1_2_11_22_1","first-page":"105","article-title":"Effects of Policosanol and Pravastatin on Lipid Profile, Platelet Aggregation and Endothelemia in Older Hypercholesterolemic Patients","volume":"19","author":"Casta\u00f1o G.","year":"1999","journal-title":"International Journal of Pharmacology and Clinical Research"},{"key":"e_1_2_11_23_1","first-page":"286","article-title":"Comparative Effects of Policosanol and Two HMG\u2010CoA Reductase Inhibitors on Type II Hypercholesterolemia","volume":"127","author":"Prat H.","year":"1999","journal-title":"Revista Medica de Chile"},{"key":"e_1_2_11_24_1","first-page":"7","article-title":"Results of the Multicenter Controlled Study of the Hypolipidemic Policosanol in Russia","volume":"72","author":"Nikitin I. P.","year":"2000","journal-title":"Terapevticheskii Arkhiv"},{"issue":"1","key":"e_1_2_11_25_1","first-page":"43","article-title":"Effects of Policosanol 20 Versus 40\u00a0mg\/Day in the Treatment of Patients With Type II Hypercholesterolemia: A 6 Months Double\u2010Blind Study","volume":"21","author":"Casta\u00f1o G.","year":"2001","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"2","key":"e_1_2_11_26_1","first-page":"155","article-title":"Comparison of the Efficacy and Tolerability of policosanol With Atorvastatin in Elderly Patients With Type II Hypercholesterolemia","volume":"20","author":"Casta\u00f1o G.","year":"2003","journal-title":"Drugs & Aging"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200323100-00003"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2003.09.002"},{"issue":"2","key":"e_1_2_11_29_1","first-page":"303","article-title":"Effects of Policosanol (5 and 10\u00a0mg\/day) in Adults With Serum Cholesterol Levels \u2264 5.9 Mmol\/L","volume":"22","author":"Illnait J.","year":"2013","journal-title":"IOSR Journal of Pharmacy"},{"key":"e_1_2_11_30_1","first-page":"124","article-title":"Efficacy and Safety of Policosanol and Pravastatin in Treatment of Hyperipidemia in Chinese Patients","volume":"2","author":"Wang Y.","year":"2008","journal-title":"International Journal of Drug Development and Research"},{"key":"e_1_2_11_31_1","first-page":"840","article-title":"Effects of Policosanol on Serum Lipids and Heme Oxygenase\u20101 in Patients With Hyperlipidemia","volume":"40","author":"Liu S.","year":"2012","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi [Chinese Journal of Cardiovascular Diseases]"},{"key":"e_1_2_11_32_1","first-page":"575","article-title":"Efficacy and Safety of Policosanol in Lipid\u2010Regulating Therapy in Lipid Regulating Therapy for Elderly Cardiovascular Disease Patients","volume":"17","author":"Ding Y.","year":"2015","journal-title":"Chinese Journal of Geriatric Heart Brain and Vessel Diseases"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2262"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/84.6.1543"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.2315"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.25.2.171.56942"},{"key":"e_1_2_11_37_1","unstructured":"M. P.Patrocinio N.Paranas andJ. A.Perez \u201cThe Effects of Sugar Cane Policosanol on the LDL HDL Triglyceride and Total Cholesterol Levels of Dyslipidemic Patients: A Meta\u2010Analysis \u201dAnesthesia and Medical Practice Journal(2017): AMPJ\u2013117."},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201700280"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0188-4409(00)00265-4"},{"key":"e_1_2_11_40_1","first-page":"107","article-title":"Policosanol Inhibits Cholesterol Synthesis in Hepatoma Cells by Activation of AMP\u2010Kinases","volume":"106","author":"Singh D. K.","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"e_1_2_11_41_1","first-page":"307","article-title":"Regulation of HMGCoA Reductase by Policosanol and Octacosadienol, a New Synthetic Analogue of Octacosanol","volume":"44","author":"Oliaro S.","year":"2009","journal-title":"Lipids"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-011-3540-6"},{"key":"e_1_2_11_43_1","first-page":"660","article-title":"Effects and Mechanism of Action of Policosanol on Decreasing Cholesterol in Patients With Hypercholesterolemia","volume":"30","author":"He F.","year":"2015","journal-title":"WCJPS"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00250.x"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1996.0086"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1997.0201"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-3278(98)90130-2"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2002.03746.x"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12204"},{"issue":"6","key":"e_1_2_11_50_1","first-page":"14","article-title":"Effects of Policosanol on the Recovery of Ischemic Stroke: A Randomized Controlled Study","volume":"2","author":"S\u00e1nchez J.","year":"2013","journal-title":"IOSR Journal of Pharmacy"},{"issue":"4","key":"e_1_2_11_51_1","first-page":"31","article-title":"Effects of Policosanol Plus Aspirin Therapy on the Neurological Recovery and Plasma Oxidative Markers of Patients With Ischemic Stroke","volume":"3","author":"S\u00e1nchez J.","year":"2013","journal-title":"IOSR Journal Of Pharmacy"},{"issue":"1","key":"e_1_2_11_52_1","first-page":"7","article-title":"Policosanol Versus Atorvastatin on the Functional Recovery of Patients With Ischemic Stroke","volume":"37","author":"S\u00e1nchez J.","year":"2016","journal-title":"International Journal of Pharmaceutical Sciences Review and Research"},{"key":"e_1_2_11_53_1","first-page":"153","article-title":"Long Term Effect of Policosanol on the Functional Recovery of Non\u2010Cardioembolic Ischemic Stroke: A One Year Study","volume":"64","author":"Sanchez J.","year":"2017","journal-title":"Revista de Neurologia"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00412"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4809525"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16050809"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065185"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2019.05.023"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(98)85030-3"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(99)80024-1"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2004.12.004"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14948"},{"key":"e_1_2_11_63_1","unstructured":"World Medical Association.Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects(Revised in Helsinki Octuber 2024)."},{"key":"e_1_2_11_64_1","article-title":"Comparative Analysis of Hypertension Guidelines: Unveiling Consensus and Discrepancies in Lifestyle Modifications for Blood Pressure Control","volume":"12","author":"Wang Y.","year":"2023","journal-title":"Cardiology Research and Practice"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.1421"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"e_1_2_11_67_1","unstructured":"NIA Adverse Event and Serious Adverse Event Guidelines https:\/\/www.google.com\/search?client=firefox\u2010b\u2010d&;q=NIA+AdverseEventandSeriousAdverse+Event+Guidelines."},{"key":"e_1_2_11_68_1","unstructured":"The Use of the WHO\u2010UMC System for Standardised Case Causality Assessment https:\/\/www.who.int\/publications\/m\/item\/WHO\u2010causality\u2010assessment."},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00590-0"},{"issue":"1","key":"e_1_2_11_70_1","article-title":"The Efficacy of Antihypertensive Drugs in Lowering Blood Pressure and Cardiovascular Events in the Elderly Population: A Systematic Review and Meta\u2010Analysis","volume":"16","author":"Chaudhry R.","year":"2024","journal-title":"Cureus"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/10641963.2025.2465399"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.70126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:17:58Z","timestamp":1761805078000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jch.70126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1111\/jch.70126"],"URL":"https:\/\/doi.org\/10.1111\/jch.70126","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"type":"print","value":"1524-6175"},{"type":"electronic","value":"1751-7176"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70126"}}